Dar Zavain 4
4 · RECURSION PHARMACEUTICALS, INC. · Filed Oct 4, 2023
Insider Transaction Report
Form 4
Dar Zavain
Director
Transactions
- Award
Class A Common Stock
2023-10-02+1,920→ 73,964 total
Footnotes (1)
- [F1]The shares were issued pursuant to the Issuer's Outside Director Compensation Policy